522 related articles for article (PubMed ID: 15495218)
21. Expression of a truncated keratin 5 may contribute to severe palmar--plantar hyperkeratosis in epidermolysis bullosa simplex patients.
Livingston RJ; Sybert VP; Smith LT; Dale BA; Presland RB; Stephens K
J Invest Dermatol; 2001 Jun; 116(6):970-4. PubMed ID: 11407989
[TBL] [Abstract][Full Text] [Related]
22. Novel keratin 14 gene mutations in patients from Hungary with epidermolysis bullosa simplex.
Csikós M; Szalai Z; Becker K; Sebõk B; Schneider I; Horváth A; Kárpáti S
Exp Dermatol; 2004 Mar; 13(3):185-91. PubMed ID: 14987259
[TBL] [Abstract][Full Text] [Related]
23. Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis.
Arin MJ; Oji V; Emmert S; Hausser I; Traupe H; Krieg T; Grimberg G
Br J Dermatol; 2011 Feb; 164(2):442-7. PubMed ID: 21271994
[TBL] [Abstract][Full Text] [Related]
24. Mechanical stress induces profound remodelling of keratin filaments and cell junctions in epidermolysis bullosa simplex keratinocytes.
Russell D; Andrews PD; James J; Lane EB
J Cell Sci; 2004 Oct; 117(Pt 22):5233-43. PubMed ID: 15454576
[TBL] [Abstract][Full Text] [Related]
25. Keratin gene mutations in human skin disease.
Stevens HP; Rustin MH
Postgrad Med J; 1994 Nov; 70(829):775-9. PubMed ID: 7529919
[No Abstract] [Full Text] [Related]
26. Keratin genes and epidermolytic hyperkeratosis.
Burton JL
Lancet; 1994 Oct; 344(8930):1103-4. PubMed ID: 7523811
[No Abstract] [Full Text] [Related]
27. Keratins and skin disease.
Knöbel M; O'Toole EA; Smith FJ
Cell Tissue Res; 2015 Jun; 360(3):583-9. PubMed ID: 25620412
[TBL] [Abstract][Full Text] [Related]
28. Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly.
Müller FB; Küster W; Wodecki K; Almeida H; Bruckner-Tuderman L; Krieg T; Korge BP; Arin MJ
Hum Mutat; 2006 Jul; 27(7):719-20. PubMed ID: 16786515
[TBL] [Abstract][Full Text] [Related]
29. Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseases.
D'Alessandro M; Morley SM; Ogden PH; Liovic M; Porter RM; Lane EB
Gene Ther; 2004 Aug; 11(16):1290-5. PubMed ID: 15215887
[TBL] [Abstract][Full Text] [Related]
30. Linkage of the epidermolytic hyperkeratosis phenotype and the region of the type II keratin gene cluster on chromosome 12.
Bonifas JM; Bare JW; Chen MA; Lee MK; Slater CA; Goldsmith LA; Epstein EH
J Invest Dermatol; 1992 Nov; 99(5):524-7. PubMed ID: 1385543
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens.
Rothnagel JA; Traupe H; Wojcik S; Huber M; Hohl D; Pittelkow MR; Saeki H; Ishibashi Y; Roop DR
Nat Genet; 1994 Aug; 7(4):485-90. PubMed ID: 7524919
[TBL] [Abstract][Full Text] [Related]
32. Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix.
Sprecher E; Ishida-Yamamoto A; Becker OM; Marekov L; Miller CJ; Steinert PM; Neldner K; Richard G
J Invest Dermatol; 2001 Apr; 116(4):511-9. PubMed ID: 11286616
[TBL] [Abstract][Full Text] [Related]
33. A unique pattern of dyskeratosis characterizes epidermolytic hyperkeratosis and epidermolytic palmoplantar keratoderma.
Bergman R; Khamaysi Z; Sprecher E
Am J Dermatopathol; 2008 Apr; 30(2):101-5. PubMed ID: 18360110
[TBL] [Abstract][Full Text] [Related]
34. Epidermolytic hyperkeratosis type PS-1 caused by aberrant splicing of KRT1.
Tal O; Bergman R; Alcalay J; Indelman M; Sprecher E
Clin Exp Dermatol; 2005 Jan; 30(1):64-7. PubMed ID: 15663507
[TBL] [Abstract][Full Text] [Related]
35. Arginine in the beginning of the 1A rod domain of the keratin 10 gene is the hot spot for the mutation in epidermolytic hyperkeratosis.
Yang JM; Nam K; Kim SW; Jung SY; Min HG; Yeo UC; Park KB; Lee JH; Suhr KB; Park JK; Lee ES
J Dermatol Sci; 1999 Feb; 19(2):126-33. PubMed ID: 10098704
[TBL] [Abstract][Full Text] [Related]
36. Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis.
Bonifas JM; Matsumura K; Chen MA; Berth-Jones J; Hutchison PE; Zloczower M; Fritsch PO; Epstein EH
J Invest Dermatol; 1994 Oct; 103(4):474-7. PubMed ID: 7523529
[TBL] [Abstract][Full Text] [Related]
37. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation.
Irvine AD; McLean WH
Br J Dermatol; 1999 May; 140(5):815-28. PubMed ID: 10354017
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families.
Shamsher MK; Navsaria HA; Stevens HP; Ratnavel RC; Purkis PE; Kelsell DP; McLean WH; Cook LJ; Griffiths WA; Gschmeissner S
Hum Mol Genet; 1995 Oct; 4(10):1875-81. PubMed ID: 8595410
[TBL] [Abstract][Full Text] [Related]
39. Striate palmoplantar keratoderma arising from desmoplakin and desmoglein 1 mutations is associated with contrasting perturbations of desmosomes and the keratin filament network.
Wan H; Dopping-Hepenstal PJ; Gratian MJ; Stone MG; Zhu G; Purkis PE; South AP; Keane F; Armstrong DK; Buxton RS; McGrath JA; Eady RA
Br J Dermatol; 2004 May; 150(5):878-91. PubMed ID: 15149499
[TBL] [Abstract][Full Text] [Related]
40. Keratin disorders: from gene to therapy.
McLean WH; Moore CB
Hum Mol Genet; 2011 Oct; 20(R2):R189-97. PubMed ID: 21890491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
